| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
and the Dutch Guillain-Barre Study Group*; *The participants of the Dutch GBS trial have been listed elsewhere (van der Meche et al., 1992 *RF 12*).
From the Department of Neurology, University Hospital Dijkzigt and Erasmus University, Rotterdam, The Netherlands.
Received December 14, 1995. Accepted in final form March 6, 1996.
Address correspondence and reprint requests to Dr Visser, Department of Neurology, University Hospital Dijkzigt and Erasmus University, Rotterdam, Ee 2242, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands.
Guillain-Barre syndrome (GBS) is usually preceded by infections, in particular cytomegalovirus (CMV) and Campylobacter jejuni infection. We studied the clinical and electrophysiologic features of 20 CMV-associated GBS patients and compared the findings with earlier established data of C. jejuni-related GBS patients (n = 43) and of GBS patients without these infections (n = 71). The patients all participated in the Dutch GBS trial in which we compared the effect of intravenous immune globulins and plasma exchange. We demonstrate that CMV-related GBS patients have a different clinical pattern in comparison with the other two GBS groups. They are significantly younger, initially have a severe course indicated by a high frequency of respiratory insufficiency, and often develop cranial nerve involvement and severe sensory loss. This is in contrast to C. jejuni infection, which is associated with motor GBS. Both infections are associated with delayed recovery compared with the GBS patients without these infections.
NEUROLOGY 1996;47: 668-673
This article has been cited by other articles:
|
|
 |
|
  J Pritchard What's new in Guillain-Barre syndrome? Postgrad. Med. J., October 1, 2008; 84(996): 532 - 538. [Full Text] [PDF]
|
|
|
|
 |
|
 S Agrawal, D Peake, and W P Whitehouse Management of children with Guillain-Barre syndrome Arch. Dis. Child. Ed. Pract., December 1, 2007; 92(6): 161 - 168. [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Yu, S. Usuki, and T. Ariga Ganglioside Molecular Mimicry and Its Pathological Roles in Guillain-Barre Syndrome and Related Diseases Infect. Immun., December 1, 2006; 74(12): 6517 - 6527. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Pritchard What's new in Guillain-Barre syndrome? Practical Neurology, August 1, 2006; 6(4): 208 - 217. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kuwabara, K. Ogawara, S. Misawa, M. Koga, M. Mori, A. Hiraga, T. Kanesaka, T. Hattori, and N. Yuki Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barre syndrome? Neurology, August 10, 2004; 63(3): 529 - 533. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hiraga, M. Mori, K. Ogawara, T. Hattori, and S. Kuwabara Differences in patterns of progression in demyelinating and axonal Guillain-Barre syndromes Neurology, August 26, 2003; 61(4): 471 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Willison and N. Yuki Peripheral neuropathies and anti-glycolipid antibodies Brain, December 1, 2002; 125(12): 2591 - 2625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.D.M. Hadden, H. Karch, H.-P. Hartung, J. Zielasek, B. Weissbrich, J. Schubert, A. Weishaupt, D.R. Cornblath, A.V. Swan, R.A.C. Hughes, et al. Preceding infections, immune factors, and outcome in Guillain-Barre syndrome Neurology, March 27, 2001; 56(6): 758 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Seneviratne Guillain-Barre syndrome Postgrad. Med. J., December 1, 2000; 76(902): 774 - 782. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. K. Asbury New Concepts of Guillain-Barre Syndrome J Child Neurol, March 1, 2000; 15(3): 183 - 191. [Abstract] [PDF]
|
|
|
|
|
|
I. S. J. Merkies, P. I. M. Schmitz, F. G. A. van der Meche, and P. A. van Doorn Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies Neurology, February 22, 2000; 54(4): 943 - 949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Van Koningsveld, P. A. Van Doorn, P. I. M. Schmitz, C. W. Ang, and F. G. A. Van der Meche Mild forms of Guillain-Barre syndrome in an epidemiologic survey in the Netherlands Neurology, February 8, 2000; 54(3): 620 - 620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kaida, S. Kusunoki, K. Kamakura, K. Motoyoshi, and I. Kanazawa Guillain-Barre syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a Brain, January 1, 2000; 123(1): 116 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Karussis, H. L Weiner, and O. Abramsky Multiple sclerosis vs Lyme disease: A case presentation to a discussant and a review of the literature Multiple Sclerosis, December 1, 1999; 5(6): 395 - 402. [PDF]
|
|
|
|
|
|
L. H. Visser, P. I. M. Schmitz, J. Meulstee, P. A. van Doorn, and F. G. A. van der Meche Prognostic factors of Guillain-Barre syndrome after intravenous immunoglobulin or plasma exchange Neurology, August 1, 1999; 53(3): 598 - 598. [Abstract] [Full Text]
|
|
|
|
|
|
M. Mori, S. Kuwabara, M. Miyake, M. Dezawa, E. Adachi-Usami, H. Kuroki, M. Noda, and T. Hattori Haemophilus influenzae has a GM1 ganglioside-like structure and elicits Guillain-Barre syndrome Neurology, April 1, 1999; 52(6): 1282 - 1282. [Abstract] [Full Text]
|
|
|
|
 |
|
 H.-P. HARTUNG Infections and the Guillain-Barre syndrome J. Neurol. Neurosurg. Psychiatry, March 1, 1999; 66(3): 277 - 277. [Full Text]
|
|
|
|
|
|
A. Khalili-Shirazi, N. Gregson, I. Gray, J. Rees, J. Winer, and R. Hughes Antiganglioside antibodies in Guillain-Barre syndrome after a recent cytomegalovirus infection J. Neurol. Neurosurg. Psychiatry, March 1, 1999; 66(3): 376 - 379. [Abstract] [Full Text]
|
|
|
|
|
|
M. TSUKAGUCHI, Y. TAGAWA, H. TAKEUCHI, and N. YUKI IgM anti-GM2 antibody in a patient with Guillain-Barre syndrome subsequent to cytomegalovirus hepatitis cross reacts with N-acetylgalactosaminyl GD1a J. Neurol. Neurosurg. Psychiatry, September 1, 1998; 65(3): 407a - 408. [Full Text]
|
|
|
|
|
|
L. Visser, F. van der Meche, J Meulstee, P. van Doorn, and the Dutch Guillain-Barre study group Risk factors for treatment related clinical fluctuations in Guillain-Barre syndrome J. Neurol. Neurosurg. Psychiatry, February 1, 1998; 64(2): 242 - 244. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
